| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $698.8M | +3.5% |
| R&D Expense | $79.7M | +5.4% |
| SG&A Expense | $139.4M | +5.4% |
| Operating Income | $252K | -89.6% |
| Pre-tax Income | -$35.3M | +19.7% |
| Income Tax | $5.8M | +252.8% |
| Net Income | -$41.1M | +9.9% |
| EPS (Basic) | -$0.22 | +8.3% |
| EPS (Diluted) | -$0.22 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $135.8M | +46.6% |
| Accounts Receivable | $40.2M | -11.6% |
| Current Assets | $218.3M | +21.2% |
| Total Assets | $1.42B | -6.4% |
| Current Liabilities | $110.7M | -5.7% |
| Long-term Debt | $527.9M | -0.8% |
| Total Liabilities | $670.4M | -3.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $113.2M | +8.2% |
| Capital Expenditures | $1.5M | -51.9% |
| Investing Cash Flow | -$12.3M | +67.7% |
| Financing Cash Flow | -$59.6M | +10.5% |
| Free Cash Flow | $111.7M | +10.0% |
| +8.3% |
| Stockholders' Equity |
| $750.8M |
| -9.1% |